477 related articles for article (PubMed ID: 17102154)
1. Practical review of oral antihyperglycemic agents for type 2 diabetes mellitus.
Koski RR
Diabetes Educ; 2006; 32(6):869-76. PubMed ID: 17102154
[TBL] [Abstract][Full Text] [Related]
2. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
Harrigan RA; Nathan MS; Beattie P
Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
[TBL] [Abstract][Full Text] [Related]
3. Oral antihyperglycemic therapy for type 2 diabetes mellitus.
Cheng AY; Fantus IG
CMAJ; 2005 Jan; 172(2):213-26. PubMed ID: 15655244
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of diabetes mellitus with oral hypoglycemic agents].
Takamoto I; Kadowaki T
Nihon Rinsho; 2011 Mar; 69(3):563-72. PubMed ID: 21400857
[TBL] [Abstract][Full Text] [Related]
5. [Update on new oral treatment for diabetes].
Awad J; Schindel B; Schindel Y
Harefuah; 2001 Jan; 140(1):36-9. PubMed ID: 11242897
[No Abstract] [Full Text] [Related]
6. [Pitfalls in treatment with oral antidiabetic agents].
Perusicová J
Vnitr Lek; 1998 Jan; 44(1):30-5. PubMed ID: 9750481
[TBL] [Abstract][Full Text] [Related]
7. Impact of oral antihyperglycemic therapy on all-cause mortality among patients with diabetes in the Veterans Health Administration.
Kahler KH; Rajan M; Rhoads GG; Safford MM; Demissie K; Lu SE; Pogach LM
Diabetes Care; 2007 Jul; 30(7):1689-93. PubMed ID: 17440170
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacologic treatment of diabetes].
De Montigny P; Clerc C; Descarpentries C
Perspect Infirm; 2006; 4(2):30-4. PubMed ID: 17184094
[No Abstract] [Full Text] [Related]
9. [Use of oral hypoglycemic agents in patients with chronic kidney failure].
Libardi F; Sirolli V; Cappelli P; Bonomini M
G Ital Nefrol; 2009; 26(6):679-85. PubMed ID: 19918750
[TBL] [Abstract][Full Text] [Related]
10. Emergency management of oral hypoglycemic drug toxicity.
Rowden AK; Fasano CJ
Emerg Med Clin North Am; 2007 May; 25(2):347-56; abstract viii. PubMed ID: 17482024
[TBL] [Abstract][Full Text] [Related]
11. Oral agent therapy in the treatment of type 2 diabetes.
Feinglos MN; Bethel MA
Diabetes Care; 1999 Apr; 22 Suppl 3():C61-4. PubMed ID: 10189564
[No Abstract] [Full Text] [Related]
12. [Approach to diabetic therapy. 2. Selection and the use of oral antidiabetics. 3) Biguanides and alpha-glucosidase inhibitors].
Onuma T
Nihon Naika Gakkai Zasshi; 2000 Aug; 89(8):1536-43. PubMed ID: 11062901
[No Abstract] [Full Text] [Related]
13. Type 2 diabetes and oral antihyperglycemic drugs.
Mizuno CS; Chittiboyina AG; Kurtz TW; Pershadsingh HA; Avery MA
Curr Med Chem; 2008; 15(1):61-74. PubMed ID: 18220763
[TBL] [Abstract][Full Text] [Related]
14. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
Inzucchi SE
Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144
[No Abstract] [Full Text] [Related]
15. [Modern approaches to pharmacotherapy of diabetes mellitus type II].
Kovel'man IR; Tochilkin AI; Beliaeva NF; Gorodetskiĭ VK; Kniazhev VA; Tkachenko SB; Semenov LL; Semenova NV
Vopr Med Khim; 2002; 48(4):337-52. PubMed ID: 12506608
[TBL] [Abstract][Full Text] [Related]
16. Rationale for dipeptidyl peptidase 4 inhibitors: a new class of oral agents for the treatment of type 2 diabetes mellitus.
Campbell RK
Ann Pharmacother; 2007 Jan; 41(1):51-60. PubMed ID: 17190843
[TBL] [Abstract][Full Text] [Related]
17. Exploring treatment strategies for type 2 diabetes.
Bloomgarden ZT
Diabetes Care; 2007 Oct; 30(10):2737-45. PubMed ID: 17901531
[No Abstract] [Full Text] [Related]
18. Class action. There are now five classes of diabetes pills. Each has a different way of helping you control your diabetes.
McCarren M
Diabetes Forecast; 2002 Feb; 55(2):62-6. PubMed ID: 14959671
[No Abstract] [Full Text] [Related]
19. Differential effects of oral hypoglycemic agents on glucose control and cardiovascular risk.
Uwaifo GI; Ratner RE
Am J Cardiol; 2007 Feb; 99(4A):51B-67B. PubMed ID: 17307058
[TBL] [Abstract][Full Text] [Related]
20. Optimizing antidiabetic treatment options for patients with type 2 diabetes mellitus and cardiovascular comorbidities.
Malesker MA
Pharmacotherapy; 2008 Feb; 28(2):193-206. PubMed ID: 18225965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
